期刊文献+

Fabry病的肾脏表现及治疗进展 被引量:3

原文传递
导出
摘要 Fabry病属于溶酶体蓄积病,是一种罕见的X连锁遗传性疾病,系由于先天性溶酶体α-半乳糖苷酶A活性缺陷导致鞘糖脂代谢异常,进而在体内多系统包括肾脏、皮肤、角膜及心脏等部位的异常堆积致病。Fabry病属单基因遗传病,致病基因GLA基因位于Xq22,编码α-半乳糖苷酶A。以往调查显示在男性新生儿中发病率约为1/40000。
作者 陈佳韵 陈楠
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第6期408-410,共3页 Chinese Journal of Nephrology
  • 相关文献

参考文献22

  • 1Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet, 2006, 79:31-40.
  • 2Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest, 2004, 34:236-242.
  • 3Tanaka M, Ohashi T, Kobayashi M, et al. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin Nephrol, 2005, 64:251-257.
  • 4Bekri S, Enica A, Ghafari T, et al. Fabry disease in patients with end-stage renal failure: the potential benefits of screening. Nephron Clin Pract, 2005, 101:c33-c38.
  • 5Linthorst GE, Vedder AC, Aerts JM, et al. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta, 2005, 353:201- 203.
  • 6Weidemann F, Breunig F, Beer M, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation, 2003, 108:1299-1301.
  • 7Hoffmann B, Reinhardt D, Koletzko B. Effect of enzymereplacement therapy on gastrointestinal symptoms in Fabry disease. Eur J Gastroenterol Hepatol, 2004, 16:1067-1069.
  • 8Wilcox WR, Banikazemi M, Guffon N, et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet, 2004, 75:65-74.
  • 9Guffon N, Fouilhoux A. Clinical benefit in Fabry patients given enzyme replacement therapy-a case series. J Inherit Metab Dis, 2004, 27:221-227.
  • 10Thurberg BL, Rennke H, Colvin RB, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int, 2002, 62:1933-1946.

同被引文献20

  • 1张苏华,尹广.Fabry病及其酶替代疗法[J].肾脏病与透析肾移植杂志,2004,13(6):560-565. 被引量:9
  • 2龚伟,胡伟新.Fabry病误诊为局灶节段性肾小球硬化[J].肾脏病与透析肾移植杂志,2004,13(6):584-587. 被引量:5
  • 3张静,刘彦仿,刘健,程虹,王汉民,崔继红,任丽君.Fabry肾病临床病理观察[J].诊断病理学杂志,2005,12(4):263-266. 被引量:8
  • 4李文歌.Fabry病的肾脏病变及诊治进展[J].中国医师进修杂志(内科版),2006,29(6):8-10. 被引量:4
  • 5曲利娟,刘庆宏,郑智勇,季天海,余英豪,曾玲.Fabry病肾病3例报告并文献复习[J].中国误诊学杂志,2007,7(26):6220-6223. 被引量:3
  • 6Peters FP,Vermeulen A,Kho TL. Anderson-Fabry's disease:alph-galactosidase deficiency[J].{H}LANCET,2001,(9250):138-140.
  • 7Germain DP. Fabry disease[J].{H}ORPHANET JOURNAL OF RARE DISEASES,2010,(05):30.
  • 8Lv YL,Wang WM,Pan XX. A successful screening for Fabry disease in a Chinese dialysis patient population[J].{H}CLINICAL GENETICS,2009,(02):219-221.
  • 9Monserrat L,Gimeno-Blanes JR,Mar NF. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy[J].{H}Journal of the America College of Cardiology,2007,(25):2399-2403.
  • 10Sakuraba H,Oshima A,Fukuhara Y. Identification of poin mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease[J].{H}American Journal of Hunan Genetics,1990,(05):784-789.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部